NASDAQ:PRTL 15 August 2025

Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

The FDA approved Papzimeos, the first immunotherapy for recurrent respiratory papillomatosis, after trials showed 51.4% of adults avoided surgery for 12 months. Cardinal Health will acquire Solaris Health for $1.9 billion in cash, expanding its specialty care network. RemeGen’s telitacicept met its Phase 3 endpoint in primary Sjögren’s syndrome in China. Response Therapeutics’ RDX-002 pill curbed weight regain in a Phase 2 trial.

15 August 2025

Innovation·NASDAQ:NVO·NASDAQ:PGEN·NASDAQ:PRTL

Stock Futures Rise as S&P 500 Nears Fourth Weekly Loss Amid Oil Price Surge
March 19, 2026, 6:25 PM EDT. Stock futures edged higher on Thursday evening, with Dow Jones Industrial Average and S&P 500 futures both gaining 0.2%, following comments by Israeli Prime Minister Benjamin Netanyahu that eased U.S.-Iran war anxieties. Netanyahu noted Iran's diminished capacity to enrich uranium and produce ballistic missiles, suggesting the conflict may shorten. Despite the uptick, the S&P 500 is set for a fourth straight weekly decline and has fallen below its 200-day moving average, a critical technical support level. The Dow and Nasdaq approach correction territory, down 8.3% and nearly 8% from recent highs, respectively. Analysts warn that markets may be overly optimistic about the war's economic impact as oil prices remain elevated, with West Texas Intermediate futures up over 48% this month.